BioLife Solutions names Roderick de Greef CEO; prelim Q3 rev $33.3M, FY23 guidance at low end

BIOLIFE SOLUTIONS INC

Michael Rice resigns as CEO and Chairman; Roderick de Greef appointed President, CEO, and Chairman effective Oct 19, 2023.
Preliminary Q3 2023 revenue $33.3M: cell processing $13.3M, storage $6.6M, freezers $13.4M.
FY2023 revenue guidance narrowed to low end of $144M-$158M range; expects flat to modest Q4 cell processing growth.
Garrie Richardson, former GM of biostorage and founder of SciSafe, promoted to Chief Revenue Officer.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Rice

Chief Executive Officer and Chairman

BLFS · BIOLIFE SOLUTIONS INC

Effective: 2023-10-19
Successor: Roderick de Greef
Filed: October 23, 2023, 7:59 PM ET

On October 19, 2023, Michael Rice, the Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of the Company, resigned his positions as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.

Appointed

Roderick de Greef

President and Chief Executive Officer and Chairman

BLFS · BIOLIFE SOLUTIONS INC

Effective: 2023-10-19
Filed: October 23, 2023, 7:59 PM ET

On October 19, 2023, the Board appointed Roderick de Greef as the President and Chief Executive Officer of the Company (Principal Executive Officer) and Chairman of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

BIOLIFE SOLUTIONS INC reported the quarter ended September 30, 2023 results: revenue $33.3 million. Guidance reaffirmed.

Period: the quarter ended September 30, 2023
Revenue: $33.3 million
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

Q3 Preliminary Unaudited Revenue and Updated FY2023 Guidance The Company is reporting preliminary, unaudited revenue for the third quarter of 2023 of approximately $33.3 million.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Rice resigned as Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.

Action: resigned
Role: Chief Executive Officer and Chairman

Exact text from the filing

On October 19, 2023, Michael Rice, the Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of the Company, resigned his positions as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Roderick de Greef was appointed as President and Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.

Action: appointed
Role: President and Chief Executive Officer and Chairman

Exact text from the filing

On October 19, 2023, the Board appointed Roderick de Greef as the President and Chief Executive Officer of the Company (Principal Executive Officer) and Chairman of the Board, effective immediately.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

BIOLIFE SOLUTIONS INC filing history →

Source: SEC EDGAR

accession 0001628280-23-034923

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.